Sepsis, the body's extreme response to an infection, affects 1.7 million adults in the United States annually. It stems from fungal, viral, or bacterial infections. Treatment delays of even a few hours can undermine a patient's ...
Oct 12, 2023
0
4
Hospitals participating in the 340B Drug Pricing Program, a large federal safety-net program, are financially incentivized to prescribe original biologic drugs to prevent and treat diseases in lieu of cheaper generic-like ...
Jun 21, 2023
0
6
Among the Medicare population from 2005 to 2020, Black women had less access to new mammography technology compared with white women, even when getting their mammograms at the same institution, according to a study of over ...
Oct 11, 2022
0
2
Incentives for hospitals to improve their quality and reduce costs do work, according to a new University of Michigan study.
Sep 17, 2018
0
2
(HealthDay)—In order to prevent denials, it is important to code correctly within the International Classification of Diseases, Tenth Revision (ICD-10), with specificity matching documentation, according to an article published ...
Dec 22, 2015
0
3
Cost of radiation therapy among Medicare patients varied most widely because of factors unrelated to a patient or that person's cancer, report University of California, San Diego School of Medicine researchers in the Journal ...
Aug 11, 2015
0
5
(HealthDay)—Other factors may affect chemotherapy prescription patterns more than changes in Medicare reimbursement, according to a study published online Sept. 29 in the Journal of Clinical Oncology.
Oct 8, 2014
0
0
Legislation passed in 2003 to slow the spiraling costs of drugs paid for by the federal government to treat Medicare patients has had no meaningful impact on cancer chemotherapy drug costs, say a team of researchers in the ...
Sep 29, 2014
0
0
(HealthDay)—The top five concerns of medical practice executives all relate to financial management, with dealing with increasing operating costs reported as the most difficult daily challenge, according to a report published ...
Aug 20, 2013
0
0
(HealthDay)—The clinical utility of histopathologic evaluation of cholesteatoma cysts is low in patients undergoing tympanomastoidectomy for chronic otitis media, according to research published online July 9 in The Laryngoscope.
Jul 30, 2013
0
0
